Xeris Biopharma Holdings Insider Sold Shares Worth $312,215, According to a Recent SEC Filing

MT newswire2026/11/06 20:41

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:41 PM EST, 11/06/2026 (MT Newswires) -- Kevin McCulloch, President and Chief Operating Officer, on November 05, 2026, sold 25,000 shares in Xeris Biopharma Holdings (XERS) for $312,215. Following the Form 4 filing with the SEC, McCulloch has control over a total of 1,584,208 common shares of the company, with 1,559,208 shares held directly and 25,000 controlled indirectly. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025. SEC Filing: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000119/xslF345X05/wk-form4_1794000751.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.

华尔街见闻•2026/11/06 23:26